Miroslav Radenkovic

University of Belgrade

Miroslav Radenković, MD, graduated from the Faculty of Medicine – University of Belgrade in 1995, and since 1996 he is working in the Department of Pharmacology, Clinical Pharmacology and Toxicology (Faculty of Medicine – University of Belgrade, Serbia), currently in the position of full-time professor. He received an MSc, board certified in Clinical Pharmacology, PhD, and sub-specialization in Clinical Pharmacology - Pharmacotherapy in 1999, 2000, 2004, and 2016 respectively, from the Faculty of Medicine – University of Belgrade. Recently, Dr. Radenković finished the Bioethics Masters Program at the Clarkson University, USA. Since 2002, Dr. Radenković officially has participated in research activities of several scientific projects supported by the Ministry of Science – Serbia, and currently he is an official participant of the NIH Fogarty International Center Project with the main aim of establishing a bioethics masters program at the Faculty of Medicine, University of Belgrade. In 2007 he was a senior postdoc and principal investigator of the scientific project financed by the Austrian Science Fund at the Medical University of Vienna, Austria. In 2011 Dr. Radenković acted as a book editor related to gestational diabetes (published by IntechOpen), and in 2021 Dr. Radenković acted as a book editor related to bioethics (published by Trivent Publishing).

1books edited

1chapters authored

Latest work with IntechOpen by Miroslav Radenkovic

Gestational diabetes mellitus is defined as hyperglycemia with onset or first recognition during pregnancy. The incidence of gestational diabetes is still increasing and this pathological condition has strong association with adverse pregnancy outcomes. Since gestational diabetes can have long-term pathological consequences for both mother and the child, it is important that it is promptly recognized and adequately managed. Treatment of gestational diabetes is aimed to maintain euglycemia and it should involve regular glucose monitoring, dietary modifications, life style changes, appropriate physical activity, and when necessary, pharmacotherapy. Adequate glycemic control throughout the pregnancy can notably reduce the occurrence of specific adverse perinatal and maternal outcomes. In a long-term prospect, in order to prevent development of diabetes later in life, as well to avoid associated complications, an adequate education on lifestyle modifications should start in pregnancy and continue postpartum.

Go to the book